A Puig-Pijoan, G García-Escobar, A Fernández-Lebrero, R M Manero Borràs, G Sánchez Benavides, I Navalpotro Gómez, D Cascales Lahoz, M Suárez-Calvet, O Grau-Rivera, A Boltes Alandí, M C Pont Sunyer, J Ortiz-Gil, S Carrillo-Molina, D López-Villegas, M T Abellán Vidal, M I Martínez-Casamitjana, J J Hernández Sánchez, J Peña-Casanova, J Roquer González, A Padrós Fluvià, V Puente Periz
INTRODUCTION: The analysis of the core biomarkers of Alzheimer's Disease (AD) in the cerebrospinal fluid (CSF) is recommended in the clinical units where it is available. Because of the absence of universal validated values, the determination of specific cut-off points for each center and its population is recommended. The main objective of the CORCOBIA study was to determine the cut-off points of core AD CSF biomarkers for several centers (Parc de Salut Mar, Barcelona and Hospital General de Granollers), which work with the same reference laboratory (Laboratori de Referència de Catalunya)...
August 9, 2022: Neurología